FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> Allergan | Latisse | Lumigan

FDA reviewer confirms drug's alluring side effect

An FDA reviewer is agreeing with Allergan that its glaucoma drug Lumigan also has an alluring side effect: it lengthens and thickens eyelashes. Allergan is seeking the agency's approval to sell the drug as Latisse to enhance upper eyelashes. And, as the Wall Street Journal notes, an approval would be a first for eyelash care. Report


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Email Newsletter:

More stories about Allergan   Latisse   Lumigan